Antiviral Activity of Trappin-2 and Elafin In Vitro and In Vivo against Genital Herpes
出版年份 2013 全文链接
标题
Antiviral Activity of Trappin-2 and Elafin In Vitro and In Vivo against Genital Herpes
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 87, Issue 13, Pages 7526-7538
出版商
American Society for Microbiology
发表日期
2013-05-02
DOI
10.1128/jvi.02243-12
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection
- (2012) Anna G. Drannik et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Anti-HIV-1 Activity of Elafin Is More Potent than Its Precursor's, Trappin-2, in Genital Epithelial Cells
- (2012) Anna G. Drannik et al. JOURNAL OF VIROLOGY
- Trappin-2/Elafin Modulate Innate Immune Responses of Human Endometrial Epithelial Cells to PolyI∶C
- (2012) Anna G. Drannik et al. PLoS One
- Anti-HIV-1 Activity of Elafin Depends on Its Nuclear Localization and Altered Innate Immune Activation in Female Genital Epithelial Cells
- (2012) Anna G. Drannik et al. PLoS One
- Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA viruses
- (2011) Man Yu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Herpes simplex virus type 2 virion host shutoff protein suppresses innate dsRNA antiviral pathways in human vaginal epithelial cells
- (2011) X.-D. Yao et al. JOURNAL OF GENERAL VIROLOGY
- Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa
- (2011) Tiffany Chan et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection
- (2009) Richard T Lester et al. AIDS
- Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition
- (2009) Shehzad M Iqbal et al. AIDS
- HSV-2 induces TLRs and NF-κB-dependent cytokines in cervical epithelial cells
- (2009) Hui Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract
- (2009) Mimi Ghosh et al. IMMUNOLOGY
- Human Immunodeficiency Virus Type 1 Mediates Global Disruption of Innate Antiviral Signaling and Immune Defenses within Infected Cells
- (2009) B. P. Doehle et al. JOURNAL OF VIROLOGY
- ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recognition of viral nucleic acids in innate immunity
- (2009) Mitsutoshi Yoneyama et al. REVIEWS IN MEDICAL VIROLOGY
- Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
- (2008) David M. Koelle et al. Annual Review of Medicine
- Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women
- (2008) Aisha Nazli et al. ANTIVIRAL RESEARCH
- The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function
- (2008) Kévin Baranger et al. FEBS Journal
- Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production
- (2008) S. B. Rasmussen et al. JOURNAL OF GENERAL VIROLOGY
- Cigarette Smoke Suppresses Type I Interferon-Mediated Antiviral Immunity in Lung Fibroblast and Epithelial Cells
- (2008) Carla M.T. Bauer et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Herpes Simplex Virus Type 2-Induced Mortality following Genital Infection Is Blocked by Anti-Tumor Necrosis Factor Alpha Antibody in CXCL10-Deficient Mice
- (2008) M. Thapa et al. JOURNAL OF VIROLOGY
- Herpes Simplex Virus Downregulates Secretory Leukocyte Protease Inhibitor: a Novel Immune Evasion Mechanism
- (2008) E. Fakioglu et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started